Investigation into effects of antipsychotics on ectonucleotidase and adenosine deaminase in zebrafish brain

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Fish Physiology & Biochemistry

• Publication date

  2015-07-09

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s10695-015-0093-2PMID 26156500
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Update on typical and atypical antipsychotic drugs.

  2013cited by this paper
• Antipsychotic drugs prevent the motor hyperactivity induced by psychotomimetic MK-801 in zebrafish (Danio rerio).

  2010cited by this paper
• Efficacy of atypical v. typical antipsychotics in the treatment of early psychosis: meta-analysis

  2010cited by this paper
• Purinergic signalling in the nervous system: an overview.

  2009cited by this paper
• The need for individualised antipsychotic drug therapy in patients with schizophrenia.

  2009cited by this paper
• Antipsychotic drugs inhibit nucleotide hydrolysis in zebrafish (Danio rerio) brain membranes.

  2009cited by this paper
• Schizophrenia

  2009cited by this paper
• Effects of some antipsychotics and a benzodiazepine hypnotic on the sleep-wake pattern in an animal model of schizophrenia.

  2009cited by this paper
• Zebrafish: a model system to examine the neurodevelopmental basis of schizophrenia.

  2009cited by this paper
• Identification of zebrafish A2 adenosine receptors and expression in developing embryos.

  2009cited by this paper
• Potential therapeutic interest of adenosine A2A receptors in psychiatric disorders.

  2008cited by this paper
• An update on the mechanisms of the psychostimulant effects of caffeine

  2008cited by this paper
• Modification of membrane heterogeneity by antipsychotic drugs: an X-ray diffraction comparative study.

  2008cited by this paper
• Purinergic signalling: past, present and future.

  2008cited by this paper
• Ectonucleotidases in the nervous system.

  2008cited by this paper
• Nucleotide- and nucleoside-converting ectoenzymes: Important modulators of purinergic signalling cascade.

  2008cited by this paper
• Kinetic characterization of adenosine deaminase activity in zebrafish (Danio rerio) brain.

  2008cited by this paper
• Purinergic signalling and disorders of the central nervous system

  2008cited by this paper
• Potential role of adenosine A2A receptors in the treatment of schizophrenia.

  2008cited by this paper
• Effects of haloperidol, clozapine and olanzapine on the survival of human neuronal and immune cells in vitro

  2007cited by this paper
• Comparative expression of p2x receptors and ecto-nucleoside triphosphate diphosphohydrolase 3 in hypocretin and sensory neurons in zebrafish.

  2007cited by this paper
• Adenosine deaminase-related genes: molecular identification, tissue expression pattern and truncated alternative splice isoform in adult zebrafish (Danio rerio).

  2007cited by this paper
• Physiology and pathophysiology of purinergic neurotransmission.

  2007cited by this paper
• Differential glutamate‐dependent and glutamate‐independent adenosine A1 receptor‐mediated modulation of dopamine release in different striatal compartments

  2007cited by this paper
• The protective effects of omega-3 fatty acids against MK-801-induced neurotoxicity in prefrontal cortex of rat.

  2007cited by this paper
• Psychosis pathways converge via D2High dopamine receptors

  2006cited by this paper
• Purinergic transmission in the central nervous system

  2006cited by this paper
• Comparative genomic and expression analysis of the conserved NTPDase gene family in Xenopus.

  2006cited by this paper
• Adenosine kinase, epilepsy and stroke: mechanisms and therapies.

  2006cited by this paper
• Methanol alters ecto-nucleotidases and acetylcholinesterase in zebrafish brain.

  2006cited by this paper
• Antipsychotics produce locomotor impairment in larval zebrafish.

  2006cited by this paper
• Involvement of adenosine in the neurobiology of schizophrenia and its therapeutic implications.

  2006cited by this paper
• Effect of subchronic caffeine treatment on MK-801-induced changes in locomotion, cognition and ataxia in mice

  2005cited by this paper
• Adenosine and brain function.

  2005cited by this paper
• A systematic review of the incidence of schizophrenia: the distribution of rates and the influence of sex, urbanicity, migrant status and methodology

  2004cited by this paper
• Ecto-5'-nucleotidase activity in brain membranes of zebrafish (Danio rerio).

  2004cited by this paper
• Expression of metallothionein gene during embryonic and early larval development in zebrafish.

  2004cited by this paper
• Chlorpromazine in chronic schizophrenic women: I. Experimental design and effects at maximum point of treatment

  2004cited by this paper
• Loss of KCNJ10 protein expression abolishes endocochlear potential and causes deafness in Pendred syndrome mouse model

  2004cited by this paper
• Chronic treatment with caffeine blunts the hyperlocomotor but not cognitive effects of the N-methyl-d-aspartate receptor antagonist MK-801 in mice

  2003cited by this paper
• ATP and ADP hydrolysis in brain membranes of zebrafish (Danio rerio).

  2003cited by this paper
• Molecular characterization of the zebrafish P2X receptor subunit gene family.

  2003cited by this paper
• Clozapine, olanzapine, risperidone, and haloperidol in the treatment of patients with chronic schizophrenia and schizoaffective disorder.

  2002cited by this paper
• Clozapine, Olanzapine, Risperidone, and Haloperidol in the Treatment of Patients With Chronic Schizophrenia and Schizoaffective Disorder

  2002cited by this paper
• Assessing cardiovascular risks versus clinical benefits of atypical antipsychotic drug treatment.

  2002cited by this paper
• Subjective well-being and quality of life under atypical antipsychotic treatment

  2002cited by this paper
• Chronic Treatment with Clozapine, but Not Haloperidol, Increases Striatal Ecto-5′-Nucleotidase Activity in Rats

  2001cited by this paper
• Adenosine in the central nervous system: release mechanisms and extracellular concentrations

  2001cited by this paper
• Adenosine A2B receptors behave as an alternative anchoring protein for cell surface adenosine deaminase in lymphocytes and cultured cells.

  2001cited by this paper
• Ectonucleotidases: Some recent developments and a note on nomenclature

  2001cited by this paper
• The role and regulation of adenosine in the central nervous system.

  2001cited by this paper
• The role of endogenous sensitization in the pathophysiology of schizophrenia: implications from recent brain imaging studies.

  2000cited by this paper
• Schizophrenia: a purinergic hypothesis.

  2000cited by this paper
• Drinks like a fish: zebra fish (Danio rerio) as a behavior genetic model to study alcohol effects.

  2000cited by this paper
• Increased baseline occupancy of D2 receptors by dopamine in schizophrenia.

  2000cited by this paper
• Involvement of Adenosine A2A Receptors in the Induction of C-Fos Expression by Clozapine and Haloperidol

  1999cited by this paper
• Adenosine Deaminase and A1 Adenosine Receptors Internalize Together following Agonist-induced Receptor Desensitization*

  1998cited by this paper
• Agonists of A1 and A2A adenosine receptors attenuate methamphetamine-induced overflow of dopamine in rat striatum.

  1998cited by this paper
• Adenosine-dopamine interactions in the ventral striatum Implications for the treatment of schizophrenia

  1997cited by this paper
• Role of adenosine as a modulator of synaptic activity in the central nervous system.

  1997cited by this paper
• Cell surface adenosine deaminase: much more than an ectoenzyme.

  1997cited by this paper
• Implication of ATP receptors in brain functions.

  1996cited by this paper
• Interaction of Guanine Nucleotides with [3H]Kainate and 6‐[3H]Cyano‐7‐Nitroquinoxaline‐2,3‐dione Binding in Goldfish Brain

  1993cited by this paper
• Interaction of tricyclic drug analogs with synaptic plasma membranes: structure-mechanism relationships in inhibition of neuronal Na+/K(+)-ATPase activity.

  1993cited by this paper
• Effects of the acute administration of caffeine in patients with schizophrenia.

  1990cited by this paper
• Adenosine deaminase-complexing protein from bovine kidney. Isolation of two distinct subunits.

  1988cited by this paper
• A direct colorimetric assay for Ca2+ -stimulated ATPase activity.

  1986cited by this paper
• A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

  1976cited by this paper
• The Role and Regulation of Adenosine in the Central Nervous System

  year unknowncited by this paper

• Exploring the Sensitivity of Peripheral ADA Levels Measurement in Establishing Psychosis Susceptibility

  2025cites this paper
• Changes in nucleotide and nucleoside metabolism in zebrafish brain exposed to paraquat and 6-hydroxydopamine

  2025cites this paper
• Profiling transcriptomic responses of human stem cell-derived medium spiny neuron-like cells to exogenous phasic and tonic neurotransmitters.

  2023cites this paper
• Zebrafish as a Promising Model in Translational Neurobiology and Biomedicine

  2023cites this paper
• Adenosine Receptors in Neuropsychiatric Disorders: Fine Regulators of Neurotransmission and Potential Therapeutic Targets

  2022cites this paper
• Zebrafish models: Gaining insight into purinergic signaling and neurological disorders.

  2020cites this paper
• Comprehensive functional annotation of susceptibility SNPs prioritized 10 genes for schizophrenia

  2019cites this paper
• Is adenosine associated with sudden death in schizophrenia? A new framework linking the adenosine pathway to risk of sudden death

  2018cites this paper
• Purinergic system in psychiatric diseases

  2018cites this paper
• Cell-subtype-specific changes in adenosine pathways in schizophrenia

  2018cites this paper
• Zebrafish models in neuropsychopharmacology and CNS drug discovery

  2017influential citation
• Purinergic Signalling and Neurological Diseases: An Update.

  2017cites this paper
• Purinergic Signalling and Neurological Diseases: An Update Running title: Purines and brain disorders

  2016cites this paper